Safeguard Scientifics, Inc. SFE today announced that its net proceeds from the successful completion of GE Healthcare's public tender offer for all outstanding shares of partner company Clarient, Inc. CLRT will be approximately $144 million.
The taxable gain on the transaction will be offset by tax loss carry forwards. The net proceeds represent a 3x cash-on-cash return on Safeguard's remaining cost basis in its holdings in Clarient. P
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsOfferingsHealth CareHealth Care EquipmentInformation TechnologyIT Consulting & Other Services
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in